Single‐dose evaluation of safety, tolerability and pharmacokinetics of newly formulated hydromorphone immediate‐release and hydrophilic matrix extended‐release tablets in healthy Japanese subjects without co‐administration of an opioid antagonist

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 975-984

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers

By Zhao Qinying   Janssens Luc   Verhaeghe Tom   Brashear H. Robert   Truyen Luc  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1547-1554

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers

By  

EPILEPSIA, Vol. 56, Iss. 11, 2015-11 ,pp. : 1723-1731

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety, tolerability, and pharmacokinetics of SMT C1100, a 2‐arylbenzoxazole utrophin modulator, following single‐ and multiple‐dose administration to healthy male adult volunteers

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 6, 2015-06 ,pp. : 698-707

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers

By Krishnan Suma M.   Stark Jeffrey G.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 33-40

Informa Healthcare

Access to resources Recommend Favorite